We derived a mouse model in which a mutant form of Nbs1 (Nbs1  mid8 ) 
Introduction
The DNA damage response (DDR) is a network of pathways that mediate DNA repair and DNA damage signaling. The collective functions of the DDR preserve genomic integrity and viability in the face of myriad intrinsic and extrinsic genotoxic stressors. In addition, the DDR is a barrier to tumorigenesis (Ciccia and Elledge, 2010) .
The Mre11 complex, composed of Mre11, Rad50, and Nbs1 is a sensor of DNA double-strand breaks (DSBs) and is required for the activation of the ATM axis of the DDR which parallels the ATR-Chk1 axis. The complex also plays an integral role in all aspects of DSB repair (Syed and Tainer, 2018) .
Additionally, the Mre11 complex controls a non-canonical DNA damage response implicated in suppressing oncogene-driven carcinogenesis. Expression of the neuT oncogene in mouse mammary epithelium elicits the formation of DDR markers such as 53BP1 and γH2AX foci, as well as marked heterochromatic changes.
In the context of Mre11 complex hypomorphism, those outcomes are not observed and the mice exhibit highly penetrant metastatic breast cancer. Deficiencies in other DDR components such as 53BP1 or mediators of apoptosis have little or no impact on the penetrance of neuT-induced malignancy in that experimental setting (Gupta et al., 2013) .
Several lines of evidence also indicate that the Mre11 complex is critical for the process of DNA replication. Among them: Mre11 complex components are physically associated with the replication fork in normal as well as stressed conditions (Sirbu et al., 2013) ; the complex is required for viability of proliferating cells but dispensable for that of quiescent cells (Adelman et al., 2009) ; and the association of the complex with chromatin is qualitatively and quantitatively distinct in S phase compared to DNA damage induced association (Maser et al., 2001; Mirzoeva and Petrini, 2003) .
Collectively, these observations underscore the fact that with respect to preserving genomic integrity, DNA replication is an important nexus of regulation in normal as well as pathologic states, and that the Mre11 complex plays a central role at that nexus.
Whereas Mre11 and Rad50 orthologs are readily identifiable in all branches of life, Nbs1 (or Xrs2 in S. cerevisiae) orthologs are found only in Eukarya (Stracker and Petrini, 2011) . Nbs1 interacts with Mre11 via a bipartite domain near its C terminus (Schiller et al., 2012) . We previously derived a series of Nbs1 alleles that targeted the Nbs1-Mre11 interface (called Nbs1 mid mutants for Mre11 interaction domain) so that the functionality of Nbs1 in isolation from the core Mre11-Rad50 complex could be assessed. The alleles that most severely impaired the interaction (Nbs1 mid5 and Nbs1 mid8 ) were lethal in MEFs and embryos. Conversely, a 108 amino acid fragment of Nbs1 that contained the bipartite Mre11 binding interface was sufficient to confer viability in MEFs as well as in the hematopoietic system (Kim et al., 2017) . These data indicate that the essential function of Nbs1 is to stabilize and promote assembly of the active form of the Mre11-Rad50 core complex.
In this study, we used a hematopoietic cell specific cre (cre vav ) (Stadtfeld and Graf, 2005) to test the hypothesis that the Nbs1 mid8 gene product, which lacks four amino acids of the Mre11 interaction domain, specified sufficient residual function to support viability in the bone marrow. The hematopoietic compartment was chosen for this experiment because it is dispensable for embryogenesis and even severe deficits in hematopoietic development are compatible with postnatal viability in mice.
cre vav was expressed in compound heterozygous mice containing floxed NBS1 (Nbs1 flox ) (Demuth et al., 2004) 
Results

Nbs1 -/mid8vav and hematopoiesis
Each member of the Mre11 complex is essential for viability at the cellular and embryonic levels. Genetic analyses of Mre11 and Rad50 have provided insights regarding their essential functions, whereas the essential role of Nbs1 has been less clear (Stracker and Petrini, 2011) . Recently, we showed that the Mre11 interaction domain of Nbs1 is necessary and sufficient for cellular viability, and that Nbs1's role is to promote assembly, activity, and nuclear localization of the Mre11 complex (Kim et al., 2017) . In that study, a series of alleles in mice that impair the Nbs1 Mre11 interaction to varying extents were derived (Nbs1 mid mice).
The Nbs1 mid8 allele, in which coding sequence for four amino acids is deleted from the Mre11 interaction domain (LKNFKKFKK; bold underlined amino acids deleted), abolishes ATM activation, was found to be embryonic lethal, and was unable to support the viability of immortalized murine embryonic fibroblasts (MEFs) (Kim et al., 2017) .
The Mre11 complex is required for hematopoiesis (Adelman et al., 2009; Balestrini et al., 2016; Callen et al., 2007; Reina-San-Martin et al., 2005) . We asked whether the Nbs1 mid8 gene product had sufficient residual function to allow hematopoietic stem cells expressing only Nbs1 mid8 to support hematopoietic development. We chose hematopoiesis because although it is essential for postnatal viability, relatively severe defects are tolerated. And, we reasoned that amidst the abundant cellularity of the hematopoietic system, productive assemblies of Nbs1 mid8 with the Mre11-Rad50 core might occur at a sufficient frequency to promote the development of at least a pauciclonal hematopoietic compartment if Nbs1 mid8 retained some functionality.
Nbs1 mid8 mice were crossed to Nbs1 flox mice (Demuth et al., 2004) . The ensuing Nbs1 flox/mid8 mice were then crossed to vav cre in which cre expression is restricted to hematopoietic stem cells (Stadtfeld and Graf, 2005) (Kim et al., 2017) . Hence, the viability of Nbs1 -/mid8vav bone marrow components was unexpected, and suggested the possibility of underlying compensatory genetic changes.
Hematopoiesis was severely impaired in Nbs1 -/mid8vav mice and did not phenocopy Atm -/-vav . Peripheral blood counts at six to eight weeks of age showed that both WBC and RBC numbers were decreased drastically in Nbs1 -/mid8vav compared to
Nbs1
-/+vav mice, WBC; 8.66 ± 0.76 vs. 1.01 ± 0.14 (x10 6 /ml), RBC; 9.99 ± 0.38 vs. 2.51 ± 0.62 (x10 9 /ml) ( Figure 1A and B). The percentage of both peripheral T cells and B cells also decreased in Nbs1 -/mid8vav , T cell (%); 36.4, 26.7 vs. 0.4, 7.6, 9.8, B cell (%); 50.9, 58.4 vs. 2.9, 1.6, 8.3 ( Figure 1D and E). Nbs1 -/mid8vav mice also exhibited a two fold elevation in platelet levels, likely a consequence of anemia ( Figure 1C ).
The cellularity of the thymus and bone marrow was also markedly decreased in
-/mid8vav mice ( Figure 1F and G Figure 2E ), the levels of B220 + cells decreased beginning at the pre B stage when immunoglobulin heavy chain rearrangement commences (Alt et al., 2013; Teng and Schatz, 2015) to the immature B cell stage (CD43 -), and IgM + mature B cells were virtually undetectable ( Figure 2F -H). These data suggest that Nbs1 -/mid8vav cells are unable to resolve DSBs formed during the course of B cell development, reminiscent of previous analyses of lymphocyte development in Mre11 complex mutants (Balestrini et al., 2016; Callen et al., 2007; Deriano et al., 2009; Helmink et al., 2009 (Balestrini et al., 2016 ) ( Figure 3A ). In addition to exhibiting higher penetrance, the malignancies were distinct from those arising in Figure S1 ) prior to the emergence of malignant cells.
Genomic analysis of Nbs1 mid8 T cell lymphoma.
To gain insight regarding the underlying genetic changes that suppressed the lethality of the Nbs1 mid8 allele, we carried out genomic analyses of Nbs1
tumors. Analysis of copy number variation (CNV) indicated the presence of multiple broad DNA copy number gains and losses, with recurrent CNV on chromosomes 9 and 15 ( Figure 4A ). A focal amplification of 9qA2 was present in all tumors albeit with variable amplitudes and breakpoints ( Figure S2 ). This region includes the genes encoding MRE11 and CHK1. Chromosome 9 amplification appears to be unique to
-/mid8vav tumors as amplification of this region has not been observed in thymic lymphomas from p53 or ATM deficient mice (Dudgeon et al., 2014; Genik et al., 2014; Zha et al., 2010) . Thus, the evolution of Nbs1 -/mid8vav malignancy is distinct.
Amplification was correlated with increased protein levels of Mre11 in Nbs1 -/mid8 thymic tumors. Although there was no CNV for the Rad50 gene, Rad50 protein levels were also increased ( Figure 4B was not restored ( Figure 4B ).
In this context, we sought to define when these two gene amplifications occurred in the transition to malignancy. We measured the copy numbers of genes that are present in chromosomes 9 or 15 at earlier times (4 and 9 week-old) prior to the age of tumor onset. Increased copy number of the MRE11 and CHK1 genes on chromosome 9 was detected in Nbs1 -/mid8 thymocytes as early as four weeks of age (1.46-fold for MRE11; 1.48-fold for CHK1) while the NBS1 copy number was not altered ( Figure 4C ).
MYC amplification on chromosome 15 was also detected in thymocytes of four week-old
-/mid8 mice (1.38-fold), suggesting that amplifications on both chromosomes 9 and 15 occurred at an early stage in the leukemogenic process, presumably reflecting selection pressure for cell survival.
The finding of CHK1 amplification in Nbs1 -/mid8vav T cell leukemias was reminiscent of the fact that human T-ALL commonly exhibits CHK1 overexpression, and are exquisitely sensitive to Chk1 inhibition (Sarmento et al., 2015) . Because the MRE11 and CHK1 loci are linked on chromosome 9, it is unclear whether their respective copy number increases are independent events or occurred simultaneously.
Deep targeted sequencing of 578 key cancer-associated genes to identify potential drivers of T-ALL in Nbs1 -/mid8vav mice revealed that the mutational features of
-/mid8vav tumors were consistent with those of T-cell acute lymphoblastic leukemia (T-ALL) in humans and are similar, but not identical to lymphomas arising in Atm -/-mice.
-/mid8vav leukemias uniformly contained activating mutations of Notch1 which are mainly restricted to the PEST domain of the NOTCH1 protein (Table S1 and Figure S3 )
as seen in human T-ALL (Weng et al., 2004) . Amplification or activating mutations in Notch1 have been also been noted in thymic lymphomas arising in ATM deficient mice (Zha et al., 2010) . Those lymphomas also contain trisomy 15 and Nbs1 -/mid8vav tumors similarly appear to have whole chromosome 15 duplications ( Figure 4A ) (Zha et al., 2010) .
Beyond Notch1, mutations of other potential driver genes were found at various frequencies in Nbs1 -/mid8vav tumors ( Figure 4D and Table S1 ). Trp53 mutations within the DNA binding domain were found with a high frequency, and were frequently biallelic due to LOH ( Figure 4D and Figure S3 ). The two mutations observed (S238P corresponding to human S241 and truncation of oligomerization domain) affect DNA binding and p53-mediated cell growth suppression functions (Fischer et al., 2016; Maki, 1999; Monti et al., 2002; Rajagopalan et al., 2010) , suggesting that p53 deficiency may be a driver of Nbs1 mid8VAV T-ALL. Other candidate driver mutations found in Nbs1
tumors including Arid5b, Bcl6, Bcor, and Ikzf1 ( Figure 4D and Table S1 ).
Overexpression of MRE11 and CHK1 rescues the lethality of Nbs1 mid8 allele in
MEFs.
To test the interpretation that Mre11 amplification and overexpression are compensatory changes that can suppress Nbs1 mid8 lethality, we overexpressed the murine Mre11 cDNA in Nbs1 flox/mid8 creERT2 MEFs (Kim et al., 2017 As noted above, the Mre11 complex plays an integral role in DNA replication (Stracker and Petrini, 2011; Syed and Tainer, 2018) . Consistent with this interpretation, cells in which the Mre11 complex is impaired experience signs of DNA replication stress (Bruhn et al., 2014) . On that basis, we tested the hypothesis that the co-amplification of the CHK1 locus uniformly observed ( Figure   4A and C) is an obligate event for viability of Nbs1 -/mid8vav . Therefore, CHK1 and MRE11 were co-overexpressed to determine whether this would rescue Nbs1 Figure S4 ).
The Nbs1 -/mid8 CM clones exhibited slower growth than the parental Nbs1 F/mid8 CM cells ( Figure 5A ). Mre11 and Chk1 levels were increased in three
Nbs1
-/mid8 CM clones ( Figure 5B ). We also found that in clone #2, Nbs1 levels were also increased ( Figure 5B ) due to 7.7-fold amplification of the Nbs1 mid8 locus in that clone ( Figure 5C ), likely in response to selective pressure imposed by the impaired interaction of Mre11 and Nbs1 mid8 .
To Figure 5D and E). Whereas CHK1 overexpression alone had no effect, MRE11 overexpression alone was sufficient to reduce DNA damage in Nbs1 -/mid8 cells ( Figure 5D and E) even though MRE11-expressing Nbs1 -/mid8 clones were not ultimately viable. This indicates that although overexpression of MRE11 was sufficient to alleviate some of genomic instability of Nbs1 mid8 , coincident CHK1
overexpression was required for cell viability.
Discussion
In previous work, we established evidence that the essential function of Nbs1 was to stabilize and promote proper assembly and function of the Mre11 complex using biochemical approaches and atomic force microscopy. In Nbs1 -/mid8 cells, Mre11
complex components are present at essentially normal levels, but Nbs1 mid8 interaction with Mre11 is compromised, blocking viability. Four days after inactivation of the wild type allele in Nbs1 flox/mid8 MEFs (prior to death), ATM activation was abolished and severe genomic instability was evident (Kim et al., 2017) . In this study, we used the context of hematopoietic development to assess whether Nbs1 mid8 retained residual function.
Whereas Nbs1 deficiency in the bone marrow led to peri-natal lethality due to anemia, Nbs1 -/mid8vav mice were viable with a median lifespan of 169 days. Nbs1 -/mid8vav succumbed to a highly aggressive T cell malignancy that bore some hallmarks of T-ALL in humans. Genomic analysis of Nbs1 -/mid8vav cancers revealed copy number gains and overexpression of MRE11 and CHK1 in 100% of tumors analyzed. We were able to establish clonal Nbs1 -/mid8 MEF cell lines only upon co-overexpression of MRE11
and CHK1, demonstrating that increased levels of both was required to suppress Nbs1 mid8 lethality.
Mre11 Complex Assembly and Tumor Suppression
Each member of the Mre11 complex is essential and none appear to function outside of the complex. Nevertheless, Nbs1 plays a distinct role in Mre11 complex stability. For example, mutations that reduce Nbs1 levels do not grossly alter the levels of Mre11 and Rad50 (Carney et al., 1998; Williams et al., 2002) , whereas the stabilities of Mre11 and Rad50 are interdependent, so that mutations destabilizing either reduce the level of the other (Stewart et al., 1999; Theunissen et al., 2003) . Hence, Mre11 and Rad50, which are present in all clades of life constitute the core of the Mre11 complex, while Nbs1, seen only in Eukarya has evolved to promote proper assembly and activity of the complex in eukaryotes.
We propose that this function of Nbs1 underlies the selection for MRE11 locus was also amplified and overexpressed ( Figure 5B and C). This suppression is not complete, as the defect in Kap1 S824 phosphorylation upon IR treatment of Nbs1 -/mid8vav tumors was not rescued ( Figure 4B ). We interpret this to mean that the levels of putatively assembled complexes were insufficient to allow for IR-induced ATM activation.
Several mouse models of Mre11 complex hypomorphism have been described (Roset et al., 2014; Stracker and Petrini, 2011) . No predisposition to malignancy has been observed in these mutants, although in some cases the latency of tumorigenesis associated with p53 or Chk2 mutations is reduced; presumably this reflects the combined effect of genome instability and checkpoint defects associated with those mutations.
The strong cancer predisposition seen in Nbs1 -/mid8vav is distinct from other Mre11 complex single mutants, and phenocopies that of Nbs1 ∆B/∆B Atm -/-vav mice. Two features of these mice likely underlie the similar outcomes (Balestrini et al., 2016) . First, ATM activity is virtually absent in the former and completely absent in the latter, which means that in both contexts, DNA damage dependent cell cycle checkpoints and apoptotic induction are compromised. Second, both exhibit high degrees of genomic instability, which likely increases the probability of chromosome rearrangement and/or mutations that enhance progression to the malignant phenotype.
The Requirement for CHK1 Overexpression
In Nbs1 -/mid8 MEFs, overexpression of MRE11 alone is not sufficient to restore viability. Co-overexpression of CHK1 was required to obtain stable clones ( Figure 5B ).
This finding strongly suggests that amplification and overexpression of the MRE11 and CHK1 loci in Nbs1 -/mid8vav T-ALL cells reflects the same requirement. Significantly increased copy numbers of both loci were observed as early as four weeks of age, supporting the interpretation that the overexpression of both genes is required for viability irrespective of the malignant phenotype.
Whereas MRE11 overexpression in Nbs1 -/mid8 MEFs mitigated the gross chromosome instability observed after cre meditated deletion of the Nbs1 flox allele (Figure 5E ), the requirement for CHK1 overexpression suggests an additional stress is imposed by the Nbs1 mid8 -containing Mre11 complex. It is likely that with the ATMMre11 complex axis of the DDR crippled by the Nbs1 mid8 allele, selection for CHK1 overexpression is imposed by the genomic instability associated with severe Mre11 complex hypomorphism. In this scenario, Chk1 function may mitigate the lethal effects of DNA damage in parallel with its normal role in the response to DNA replication stress.
DNA replication stress, broadly defined as a state in which progression of the replisome is impaired by DNA lesions or insufficiency of the nucleotide pool is an important source of DNA damage in proliferating cells. DNA replication stress also appears to be intrinsic to the premalignant and malignant phenotypes (Gaillard et al., 2015; Macheret and Halazonetis, 2015) . The viability of cells experiencing DNA replication stress is largely dependent on the ATR-Chk1 axis of the DNA damage response (Schoppy et al., 2012; Zeman and Cimprich, 2014) , and so the development of Chk1 and ATR inhibitors has emerged as a priority in cancer therapeutics (Pilie et al., 2018) .
Given its requirement for preserving genomic integrity during S phase (Adelman et al., 2009) , it is also conceivable that the selection for CHK1 overexpression reflects that Mre11 complex depletion causes DNA replication stress in a manner analogous to depletion of MCM proteins and other replisome components (Hills and Diffley, 2014) , a state that acutely requires Chk1 activity to maintain viability (Gaillard et al., 2015; Schoppy et al., 2012) .
Cytologic analyses of acute Nbs1 depletion in MEFs offered the suggestion that the Mre11 complex's role in resolving DNA replication intermediates underlies its essentiality (Bruhn et al., 2014) . Perhaps consistent with that view, we have shown that Mre11 complex foci arise during unperturbed S phase. Those foci do not colocalize with DSB markers such as γH2AX or BRCA1, but colocalize with PCNA throughout S phase (Maser et al., 2001; Mirzoeva and Petrini, 2003) . Hence, they do not appear to be associated with DSBs and could potentially represent DNA replication intermediates that precede fork collapse and DSB formation.
An additional possibility is that the Mre11 complex is situated at the fork to degrade secondary structures on the lagging strand and thereby drive sister chromatid recombination as has been suggested in bacteria and S. cerevisiae (Connelly and F., 1996; Connelly et al., 1998; Lobachev et al., 2002) . Whatever the source of the initiating DSBs, the Mre11 complex is acutely required for sister chromatid recombination (Stracker and Petrini, 2011) , a function that could also account for Chk1 activation upon depletion as well as the complex's association with the fork under normal conditions.
Nbs1 -/mid8vav and T-ALL in Humans
Genomic analysis of Nbs1 mid8 leukemias revealed a similar patter of mutations to that found in human T-ALL (Sarmento et al., 2015; Weng et al., 2004) . The Notch1 mutations were found in 6 tumors out of 7 samples analyzed and the mutations were restricted to the PEST domain, as seen in human T-ALL and also T-ALL arising in Atm -/-vav mice (Weng et al., 2004; Zha et al., 2010) . This suggests that Notch1 mutations could be the main driver for T-ALL tumors. Other mutations found in Nbs1
leukemias are also known human tumor mutations. For example, Bcl6, Bcor, and Ikzf1
are found mutated in human T-ALL and B-ALL (Kastner and Chan, 2011; Mullighan et al., 2008) . Bcl6 is a regulator for germinal center reaction and found deregulated in ~40
% diffuse large B-cell lymphomas (DLBCL) by translocation (Butler et al., 2002; Lo Coco et al., 1994; Ye et al., 1993) . Loss of function mutations in Bcor has been noted in hematopoietic malignancies (Damm et al., 2013; Grossmann et al., 2011) . In this regard, Nbs1 -/mid8vav may provide an in vivo model for examining the contributions of the various driver mutations in T-ALL and other malignancies in the context of Mre11 complex hypomorphism.
The Mre11 complex plays a critical role in preventing oncogene induced carcinogenesis in mammary epithelium (Gupta et al., 2013) . It is conceivable that 
Materials and methods
Mice
The generation of Nbs1 mid8 , Nbs1 flox/flox vav cre , and Atm flox/flox vav cre mice were previously described (Balestrini et al., 2016; Kim et al., 2017 
Peripheral blood analysis
Peripheral blood was collected from the tail vein. A compete peripheral blood count was measured using a Hemavet 950 (Drew Scientific).
Flow cytometry analyses
Thymus and femurs from 6-8 week old mice were harvested and subjected to red 
Sequencing and analysis
Tumor samples along with normal samples taken from the tails of unaffected littermates underwent either a custom-capture and deep sequencing assay of 578
established cancer genes called Mouse Integrated Mutation Profiling of Actionable
Cancer Targets (M-IMPACT) or low-pass whole-genome sequencing (WGS) for additional DNA copy number analyses. Tumors were sequenced with M-IMPACT to an average 300.9-fold coverage. Analysis for somatic point mutations and small insertions and deletions along with DNA copy number changes in these data was performed a previously described (Pronier et al., 2018) . Tumors were sequenced by low-pass WGS to an average of 4.9-fold coverage. DNA copy number alterations were identified summarizing read coverage in 50kb non-overlapping windows across the genome followed by GC-content normalization using a lowess fit. We then performed circular binary segmentation (alpha of 1e-5 and undo.SD of 5) (Venkatraman and Olshen, 2007) . Structural variants were identified using delly v0.6.1 (Rausch et al., 2012) .
Cellular assays
For metaphase spread, cells were treated with 100 ng/ml of KaryoMAX colcemid 
Western Blot
Western blots were performed by standard protocol. Total cells extracts were prepared in SDS lysis buffer (60 mM Tris-HCl pH 6.8, 2% SDS) and boiled for 5 min to shear genomic DNA. Twenty microgram of extracts were analyzed for western blot.
Antibodies used in this study were MRE11 (custom made), NBS1 (custom made), RAD50 (custom made), p-KAP1 S824 (ab70369, Abcam), total KAP1 (NB500-159, Novus), CHK1 (sc-8408, Santa Cruz), and a-TUBULIN (T9026, Sigma).
Copy number qPCR
Genomic DNAs were isolated using GeneJET Genomic DNA Purification Kit (Thermo) and qPCRs were performed using SsoAdvanced™ Universal SYBR ® Green
Supermix ( with Nbs1 -/+vav and Nbs1 -/mid8vav at a given age. N denotes total number of mice for each genotype and the average age in death in days is shown. ND means not determined.
Note that the Atm -/-vav survival curve was previously established in our colony and reported (Balestrini et al., 2016) . ( The mouse identification numbers are indicated (A and D). MEFs from lethality. Figure S3 . Domain structures of mutation genes found in Nbs1 -/mid8vav tumors.
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Nbs1 mid8
Nbs1 mid8 Figure S4 . Verification of Nbs1 -/mid8 CM clones #2, #7, and #8. The RNA level of Nbs1 mid8 allele from three Nbs1 -/mid8 CM clones #2, #7, and #8 were confirmed by sequencing the amplified region by RT-PCR.
